Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Underwriter's can't lend out shares to short for 30 days after the IPO launch. This was an early Sept. baby.
Does your broker show shares available to borrow?
I am seeing zero share available but only a 0.62% short interest on my broker.
Fintel also showing zero shares available but only 0.20% short interest.
Im no genius but this doesn't add up...
They also just dropped the share price below the bid several times today, without filling a single share. So when does the order book/lvl 2 actually start to matter?
Finally had it's first consecutive green days!
Will it keep it up?
Need to break and hold above this 4.05 - 4.20 range.
It can always go down. Insider ownership here gettin rich off loaning out shares for interest. With the way this trades I wouldn't doubt there's more shares owned than are actually in the float. The volume here just doesn't make sense. They will be able to continue to paint the books until all warrants are exercised and there's no ability to fudge the numbers anymore. That may never happen...
I agree that the news was pretty much moot. I bet it was just a fake pump to create some volume for short covering. Now, they will re-short it all over again... And sell exercised shares into the market to manipulate and create the down trend they want.
Like I keep saying.. Its trash underwriters... Go look at their history, they kill 90% of the companies they IPO. Their greed is beyond immense and the SEC won't shut it down just like they won't shut down PFOF. They don't care about a free market. They only care about a controllable market. There is no intention of protecting shareholders' interests.
I believe this will go up from here. Consolidation and selling is done. People started to realize that it can't go down anymore but it has huge potential to go up with any news.
The only way to make $$$$ in a shit market. Let them pump! :)
WOW what a jump on such seemingly moot news
I warned y'all on the 16th that they were going to pump soon. They will again if it retraces. They need to pump to get this pps up. Put it on your watchlist.
Trade the chart. When/if it retraces and consolidates in quiet mode, load for the next pr. This moves on news.
Complete fluff! All this tells us is what we already knew when the IPO happened. Just a rehash of old news!
wow, they bought higher than trading price. This says something big is coming.
News: BioAffinity Technologies, Inc. (NASDAQ: BIAF) (NASDAQ: BIAFW) today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.
Investors participating in bioAffinity Technologies’ financing exercised a total of 725,576 tradeable warrants at a price of $7.35 per share and 310,910 non-tradable warrants at a price of $7.656 per share. Combined with the Company's underwritten public offering of 1,282,600 units, each consisting of one share of common stock, one tradeable warrant and one non-tradeable warrant, in which the Company announced the receipt of gross proceeds of approximately $7.9 million, the Company has received an aggregate of approximately $15.6 million as of September 28, 2022.
The Company intends to use the proceeds from the offering to expand existing operations and the commercialization of CyPath® Lung, a noninvasive test for the early detection of lung cancer which uses flow cytometry to count and characterize cells in a person’s sputum, or phlegm. The test’s automated analysis of the flow cytometry data detects cell populations that indicate cancer is present. CyPath® Lung has the potential to increase overall diagnostic accuracy of lung cancer diagnosis leading to increased survival while lowering the number of unnecessary invasive procedures, reducing patient anxiety, and lowering medical costs.
Proceeds may also be used in the Company’s pursuit of regulatory approvals and research and development of additional diagnostics, cancer therapeutics, and for working capital and general corporate purposes.
Rocket power!!!!!!
Total shares for BIAF as shown in prospectus 424B4 filed on 9/2/22:
6,098,203 Existing shareholders prior to IPO
1,282,600 New shares sold with IPO
7,380,803 Total as of June 30, 2022
Issuance Details: (there is a difference of 270,629 more than what's stated above)
2,570,650 shares of Common Stock issuable upon the exercise of the Warrants underlying the Units sold in this Offering;
192,390 shares of Common Stock issuable upon the exercise of the Over-Allotment Option
192,390 shares of Common Stock issuable upon the exercise of 192,390 Tradeable Warrants issuable upon the exercise of the Over-Allotment Option
192,390 shares of Common Stock issuable upon the exercise of 192,390 Non-tradeable Warrants issuable upon the exercise of the Over-Allotment Option
25,562 shares of Common Stock issuable upon the exercise of the Representative’s Warrant and 29,464 shares of Common Stock issuable upon the exercise of the Placement Agent’s Warrant
756,558 shares of Common stock issuable upon the conversion of Series A Preferred ?Stock
871,240 shares of ?Common Stock issuable on the exercise of stock options; and
2,850,252 shares of Common Stock issuable on the exercise of outstanding warrants issued to the holders of our convertible notes with a weighted average exercise price equal to $5.25 per share.
Pretty volatile here atm but good setup for another pump pr early next week which I'm sure insiders are looking at.
Warrants are exercisable at $7.35
Do you know what the exercise price is for the warrants and when can they be exercised
BIAFW warrants up +50% maybe commons will follow
I don't believe that to be half the float...
I understand that 1.3mill should be the float according to the information provided by our brokers. But when I dug through the filings earlier this week I came up with around 3 mil...
Dilution tracker shows OS to be around 7.3 mill. I don't pay their subscription right now, so I don't know exactly how much of the 7.3 mill is actually issued, but the company did do some sort of split before they IPO'd. I am wondering if there are previously issued shares now being sold into the market.
I am drinking right now due to the ETH merge, and I have to take off close to a megawatt of hash-power off blockchains, but I will deep dive as much as possible into the actual share structure and report back once I am sober...
Even still, share structure doesn't seem to matter these days. Institutions seem to have limitless ability to issue endless shares to create the movement they want. all because of inflation. This ability to sell endless amounts of shares regardless of SS has been quite prevalent since the GME debacle.
What happen after 30 days
610k in short exempts today!! That is half the float
This is a 9-day-old IPO, usually, there is a lock-up period. outstanding shares is only 2,700,000. Only 1,000,000 shares they could sell if no lock-up period.
The company could have been selling shares into the news
up 0.75, float 1,700,000, volume 48,350,000 float rotation of 28X. I just don't get it!!!
It's the dumbecrats they want all our money ??
What a joke. 2022 sucks, lets get on to 2023. Nothing has follow thru. This should have been so much higher today
Massive drop lol
Trash greedy underwriters...
These underwriters kill every stock that choses to IPO with them.
They really suck at what they do... Need to learn how to sell shares into the market.. But then again I guess that would actually require them to work for their money...
FTDs will be massive
Yea, halts work against retail to squash daytraders lol unfair. They cool off many runs this way.
She getting higher! Baby light my fire!!!!
6.37 HALTED^^up
CONGRAT$ BIAF profits
News: Source: Business Wire
bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, today announced publication of its research in high-throughput flow cytometry analysis of sputum. The journal PLOS ONE, published Sputum analysis by flow cytometry; an effective platform to analyze the lung environment reporting on results of analyzing sputum by flow cytometry as the basis for high-throughput diagnostic tests to determine the health of the lung.
Watching here closely everyday. This ticker will have another run on good news.
Over 10% of the float yesterday was short exempts. Something has to give. I'm in
Trash Underwriters...
That is who you are fighting.
I stopped trying to flip this on day 2. Every time I provided bid support on a building bid, they would dump the stock 25 cents below my bid and not even fill me a single share.
On the first day, every consolidation range that would slowly start to build bullish, they would dump 100,000 shares on it once the bids got even the slightest bit weak.
They are probably more interested in loaning fees for shorting than they are helping the company.
That's my 2 cents...
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
183
|
Created
|
08/05/22
|
Type
|
Free
|
Moderators |
Volume: | 132,372 |
Day Range: | 0.475199 - 0.539999 |
Last Trade Time: | 3:46:58 PM EDT |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |